Dr. Alejandra Victoria Capozzo holds a PhD in Biological Sciences from the University of Buenos Aires and completed postdoctoral training in Neonatal Immunology at the Center for Vaccine Development, University of Maryland, Baltimore. Her career has focused on applied veterinary immunology, with particular emphasis on Foot-and-Mouth Disease (FMD). She is currently Director of the Center for Advanced Studies in Health Sciences (CAECIHS) at the Universidad Abierta Interamericana and Principal Investigator at CONICET. Dr. Capozzo promotes scientific innovation within the One Health framework. She is the co-founder of Novelbiotic, a startup dedicated to the development of new antimicrobials, and holds key leadership roles in global networks. She serves as Chair of the Veterinary Immunology Committee of the IUIS, Executive Director of the Global Foot-and-Mouth Disease Research Alliance (GFRA), and Co-Chair of the FAO-WOAH Global Coordination Committee on FMD. She also leads the Latin American Network for Veterinary Immunology and is Director of the Argentine Association of Veterinary Immunology. She has authored over 70 scientific publications, coauthored eight biology books, and supervised twelve PhD theses. Her current focus is on advancing the One Health approach and strengthening regional networks to foster the development of applied immunology.